Charles Schwab Investment Management Inc. Has $26.77 Million Stock Holdings in Privia Health Group, Inc. $PRVA

Key Points

• Charles Schwab Investment Management Inc. increased its stake in Privia Health Group by 5.2%, now owning approximately 1,192,362 shares worth around $26.8 million.
• Institutional investors hold a significant portion of 94.48% of Privia Health Group's stock, reflecting strong investor confidence in the company.
• Privia Health Group reported a 23.4% increase in quarterly revenue year-over-year, amounting to $521.15 million, despite missing earnings expectations.

Charles Schwab Investment Management Inc. boosted its stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 5.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,192,362 shares of the company's stock after purchasing an additional 58,489 shares during the period. Charles Schwab Investment Management Inc. owned about 0.98% of Privia Health Group worth $26,769,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of PRVA. CWM LLC lifted its stake in shares of Privia Health Group by 50.3% in the 1st quarter. CWM LLC now owns 1,804 shares of the company's stock valued at $40,000 after acquiring an additional 604 shares during the last quarter. Bessemer Group Inc. increased its holdings in Privia Health Group by 2,393.4% in the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock worth $51,000 after purchasing an additional 2,178 shares in the last quarter. GAMMA Investing LLC raised its position in Privia Health Group by 113.1% in the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock valued at $64,000 after purchasing an additional 1,521 shares during the last quarter. Financial Management Professionals Inc. boosted its stake in shares of Privia Health Group by 28.7% during the first quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company's stock valued at $76,000 after purchasing an additional 754 shares in the last quarter. Finally, Vestcor Inc bought a new stake in shares of Privia Health Group during the first quarter worth about $76,000. Institutional investors own 94.48% of the company's stock.

Privia Health Group Price Performance

NASDAQ PRVA traded down $0.01 during mid-day trading on Tuesday, reaching $21.39. 480,415 shares of the stock were exchanged, compared to its average volume of 1,009,885. Privia Health Group, Inc. has a one year low of $16.47 and a one year high of $26.09. The stock has a 50 day simple moving average of $20.89 and a 200-day simple moving average of $22.68. The stock has a market cap of $2.63 billion, a P/E ratio of 194.47, a P/E/G ratio of 3.10 and a beta of 0.80.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by ($0.03). The firm had revenue of $521.15 million for the quarter, compared to the consensus estimate of $466.97 million. Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%.Privia Health Group's quarterly revenue was up 23.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.19 EPS. Privia Health Group has set its FY 2025 guidance at EPS. Sell-side analysts anticipate that Privia Health Group, Inc. will post 0.14 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently weighed in on PRVA. Barclays boosted their price target on Privia Health Group from $23.00 to $24.00 and gave the stock an "equal weight" rating in a report on Tuesday, May 27th. JMP Securities reaffirmed a "market outperform" rating and set a $29.00 price target on shares of Privia Health Group in a research note on Monday, April 28th. Evercore ISI dropped their price target on shares of Privia Health Group from $30.00 to $28.00 and set an "outperform" rating for the company in a research note on Wednesday, July 9th. Piper Sandler dropped their price target on shares of Privia Health Group from $36.00 to $35.00 and set an "overweight" rating for the company in a research note on Monday, August 11th. Finally, JPMorgan Chase & Co. raised their price target on shares of Privia Health Group from $29.00 to $32.00 and gave the company an "overweight" rating in a research note on Wednesday, May 28th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, Privia Health Group has a consensus rating of "Moderate Buy" and a consensus target price of $28.00.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.